This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Furling, D. Articles by Puymirat, J. Search for Related Content PubMed PubMed Citation Articles by Furling, D. Articles by Puymirat, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB 2-DEOXY-D-GLUCOSE GLUCOSE

Insulin-Like Growth Factor I Circumvents Defective Insulin Action in Human Myotonic Dystrophy Skeletal Muscle Cells¹

Laboratory of Human Genetics, Department of Medicine (D.F., J.P.), and Lipid Research Unit, Department of Physiology (A.M.), Laval University Medical Research Center, University Hospital Center of Québec , Ste-Foy, Québec, Canada G1V 4G2

Address all correspondence and requests for reprints to: Dr. Jack Puymirat, Human Genetics Laboratory, Laval University Medical Research Center, University Hospital Center of Québec, 2705 boulevard Laurier, Ste-Foy, Québec, Canada G1V 4G2. E-mail: jack.puymirat{at}crchul.ulaval.ca

Primary human skeletal muscle cell cultures derived from muscles of a myotonic dystrophy (DM) fetus provided a model in which both resistance to insulin action described in DM patient muscles and the potential ability of insulin-like growth factor I (IGF-I) to circumvent this defect could be investigated. Basal glucose uptake was the same in cultured DM cells as in normal myotubes. In DM cells, a dose of 10 nM insulin produced no stimulatory effect on glucose uptake, and at higher concentrations, stimulation of glucose uptake remained significantly lower than that in normal myotubes. In addition, basal and insulin-mediated protein synthesis were both significantly reduced compared with those in normal cells. In DM myotubes, insulin receptor messenger RNA expression and insulin receptor binding were significantly diminished, whereas the expression of GLUT1 and GLUT4 glucose transporters was not affected. These results indicate that impaired insulin action is retained in DM cultured myotubes. The action of recombinant human IGF-I (rhIGF-I) was evaluated in this cellular model. We showed that rhIGF-I is able to stimulate glucose uptake to a similar extent as in control cells and restore normal protein synthesis level in DM myotubes. Thus, rhIGF-I is able to bypass impaired insulin action in DM myotubes. This provides a solid foundation for the eventual use of rhIGF-I as an effective treatment of muscle weakness and wasting in DM.

This article has been cited by other articles:

				D.-H. Kim, M.-A. Langlois, K.-B. Lee, A. D. Riggs, J. Puymirat, and J. J. Rossi HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence Nucleic Acids Res., July 15, 2005; 33(12): 3866 - 3874. [Abstract] [Full Text] [PDF]

				S. Sato, M. Nakamura, D. H. Cho, S. J. Tapscott, H. Ozaki, and K. Kawakami Identification of transcriptional targets for Six5: implication for the pathogenesis of myotonic dystrophy type 1 Hum. Mol. Genet., May 1, 2002; 11(9): 1045 - 1058. [Abstract] [Full Text] [PDF]